SCHEMBL31458628

SCHEMBL31458628

F[C@@H]1COCC[C@@H]1Nc1nc2c(N3CC4CC3C4)c(-c3cn[nH]c3)ncn2n1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.30
PIK3CA P42336 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423935 0.90
SCHEMBL31423982 0.90
SCHEMBL31423985 0.90
SCHEMBL31423957 0.90
SCHEMBL31423991 0.90
SCHEMBL31458719 0.83 JAK2 (0.34)
SCHEMBL31458720 0.81 CNR2 (0.33)
SCHEMBL25277898 0.80 ATR (0.35) PRKDCPIK3CA
SCHEMBL31458611 0.79 PIK3CA (0.34) PIK3CA
SCHEMBL31423945 0.78 MAPK8 (0.38) PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096061-A1 CDK2 INHIBITORS AND USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed